Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
Date:2/28/2013

Randomized, Controlled Trials", Chey, W., et al. 
  • Date: May 21, 2013, 8:15 a.m. Eastern Time
  • Research Forum: New Pharmacological Treatments for Motility Disorders
  • 4th International Congress on Neuropathic Pain, Toronto, Canada:

  • Poster A-484-0002-00647: "NKTR-171: Preclinical Efficacy and Improved Central Nervous System (CNS) Side Effect Profile of a Novel Sodium Channel Blocker Designed for the Treatment of Neuropathic Pain", Gursahani, H., et al. 
  • Date: May 25, 2013, 1:30 p.m. – 3:30 p.m. Eastern Time
  • Poster Session II
  • College on Problems of Drug Dependence 75th Annual Meeting, San Diego, CA:

  • Poster 1598130: "Opioids With Lower Brain Uptake Are Less Recognizable in Rat Drug Discrimination Tests and thus Potentially Less Subject to Abuse", Harrison, S., et al. 
  • Date: June 19, 2013, 12:00 p.m. – 2:00 p.m. Pacific Time
  • Poster 1605508: "Abuse Potential Assessment of Novel Opioid Analgesic NKTR-181: Implications for Labeling", Webster, L., et al. 
  • Date: June 20, 2013, 7:30 a.m. – 9:30 a.m. Pacific Time
  • Conference Call to Discuss Fourth Quarter and Year-End 2012 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time today, Thursday, February 28, 2013.

    This press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, March 15, 2013.

    To access the conference call, follow these instructions:

    Dial: (877) 881.2183 (U.S.); (970) 315.0453 (international)
    Passcode: 98224860 (Nektar Therapeutics is the
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
    2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
    3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
    4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
    5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
    6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
    7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
    8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
    9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
    10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® in the ... that BioSpecifics, President, Tom Wegman , will present a ... in the Biotech Industry Conference. The presentation ... p.m. EDT at the Millennium Broadway Hotel in ...
    (Date:9/19/2014)... 2014 Aufgrund der enormen ... erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die Jahre ... unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit ... Kraft treten. Für international tätige Unternehmen ... das "ob", sondern darum, "wann" sie die neu ...
    (Date:9/19/2014)... -- Intarcia Therapeutics, Inc. today announced the ... candidate ITCA 650 (continuous subcutaneous delivery of exenatide) in ... at the 50 th Annual Meeting of the ... from the open-label, phase 3 FREEDOM-HBL (high baseline) trial ... with poorly controlled type 2 diabetes. The results were ...
    Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
    ... 6, 2011 This is being released by SCM: ... weeks of testimony and 4 hours of closing statements, lead ... in Clark County Nevada, Robert Eglet, asked jurors to bring ... Arnold, $2.5 million in compensatory damages for James Arnold and ...
    ... the peer-reviewed publication of unique pre-clinical data on TIGR ® ... long-term absorbable surgical mesh. The study, which was presented ... Journal of Hernia and Abdominal Wall Surgery , describes the results of ... Matrix versus a permanent mesh in a sheep model. ...
    Cached Medicine Technology:Lead Trial Attorney in Clark County Hepatitis C Trial, Robert Eglet, Asks Jury to Award $10 Million Compensatory Damages for Anne Arnold, $2.5 Million for James Arnold 2Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh 2
    (Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
    (Date:9/21/2014)... 2014 Discount-Dress.com, a company ... recently announced its decision to implement a new shopping ... for ladies across the world. Furthermore, the company has ... ladies. , The new items come in fashionable ... prices, up to 56 percent off. "We are happy ...
    (Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
    (Date:9/21/2014)... del Rio, Colorado (PRWEB) September 21, 2014 ... Vail, Colorado, ten teams of disabled and able-bodied athletes ... cycles, and completed a ropes course in pursuit of ... Challenge from national non-profit World T.E.A.M. Sports, disabilities ... participating athletes who successfully completed the three stage event. ...
    (Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
    Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
    ... KENSINGTON, Md., Sept. 8 The first-ever New Jersey Psoriasis ... 2009, at beautiful Van Saun Park. The walk, to ... Cure Now, will include entertainment, information booths on psoriasis treatments, ... with psoriasis and psoriatic arthritis. Janine Natoli of Little ...
    ... improves sleep quality in menopausal women with hot flashes, ... in the September issue of the Journal of ... women experience sleep disruption, often in the form of ... study is the first to show sustained benefits in ...
    ... , Sponsored by Chester County Eye ... WEST CONSHOHOCKEN, Pa., Sept. 8 Chester County Eye Care ... a SupportSight seminar in West Chester on September 26th. ... affected by macular degeneration and for those who would like to learn ...
    ... , , PITTSBURGH, Sept. 8 ... in toothpaste - new iso-active(R) Foaming Gel. Iso-active has a ... areas of the mouth. , , According to ... much of their tooth surface is actually hidden between the teeth. ...
    ... , MEXICO CITY, Sept. 8 ... "the Company"), one of the fastest,growing pharmaceutical and personal care ... today revisions to its,earnings guidance for the full year of ... 35%-38% and an EBITDA margin of approximately 25%. , ...
    ... in place, rates barely budge, report finds , TUESDAY, ... campaigns and widespread agreement about the importance of colorectal ... be screened do so, new research finds. , Rates ... lower still, with only 22 percent of lower-income people ...
    Cached Medicine News:Health News:First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12 2Health News:Seizure drug enhances sleep for women with hot flashes 2Health News:SupportSight Comes to West Chester, Saturday, September 26th; Free Seminar for Those Affected by Macular Degeneration 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 3Health News:Genomma Lab Internacional Revises 2009 Earnings Guidance 2Health News:Colon Cancer Screenings Still Too Low: Study 2Health News:Colon Cancer Screenings Still Too Low: Study 3
    ... The ORTHOSTAR table is the ... today. It was designed for ... body traction with an integrated ... a special purpose operating table ...
    ... is restricted. Due to its excellent drive ... every situation. For many complicated surgery positions, ... on the JUPITER during the induction to ... the high level of stability of JUPITER ...
    ... The mobile universal operating table ... table top allows for unlimited C-arm ... comfort for both neurosurgical and cardiovascular ... need for floor support can easily ...
    ... carbon fiber c-arm table allows 50 ... brachytherapy, gynecology, gastroenterology, cardiovascular, orthopedic, ENT, ... design allows easy access for all ... 16-inch elevating travel, 16-inch longitudinal travel, ...
    Medicine Products: